CoChat

The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing

Open access

The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.

Abstract

The human intestinal microbiota is essential to the health of the host and plays a role in nutrition, development, metabolism, pathogen resistance, and regulation of immune responses. Antibiotics may disrupt these coevolved interactions, leading to acute or chronic disease in some individuals. Our understanding of antibiotic-associated disturbance of the microbiota has been limited by the poor sensitivity, inadequate resolution, and significant cost of current research methods. The use of pyrosequencing technology to generate large numbers of 16S rDNA sequence tags circumvents these limitations and has been shown to reveal previously unexplored aspects of the "rare biosphere." We investigated the distal gut bacterial communities of three healthy humans before and after treatment with ciprofloxacin, obtaining more than 7,000 full-length rRNA sequences and over 900,000 pyrosequencing reads from two hypervariable regions of the rRNA gene. A companion paper in PLoS Genetics (see Huse et al., doi: 10.1371/journal.pgen.1000255) shows that the taxonomic information obtained with these methods is concordant. Pyrosequencing of the V6 and V3 variable regions identified 3,300-5,700 taxa that collectively accounted for over 99% of the variable region sequence tags that could be obtained from these samples. Ciprofloxacin treatment influenced the abundance of about a third of the bacterial taxa in the gut, decreasing the taxonomic richness, diversity, and evenness of the community. However, the magnitude of this effect varied among individuals, and some taxa showed interindividual variation in the response to ciprofloxacin. While differences of community composition between individuals were the largest source of variability between samples, we found that two unrelated individuals shared a surprising degree of community similarity. In all three individuals, the taxonomic composition of the community closely resembled its pretreatment state by 4 weeks after the end of treatment, but several taxa failed to recover within 6 months. These pervasive effects of ciprofloxacin on community composition contrast with the reports by participants of normal intestinal function and with prior assumptions of only modest effects of ciprofloxacin on the intestinal microbiota. These observations support the hypothesis of functional redundancy in the human gut microbiota. The rapid return to the pretreatment community composition is indicative of factors promoting community resilience, the nature of which deserves future investigation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pbio.0060280

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Genetic Distances between Tags and Reference Sequences The genetic distances between each unique V6 tag (A) and V3 tag (B) and its best hit (or hits) in the appropriate reference database is shown on the vertical axis (see Methods for details); the abundance of the tag is shown on a logarithmic scale on the horizontal axis. Horizontal arrows indicate cumulative totals of tags from most to least abundant. Discrete horizontal rows of symbols near the x-axis correspond to an integer number of nucleotide changes relative to a reference sequence; vertical arrows indicate cumulative tag totals for up to 0, 1, or 2 changes. Abundant tags are likely to be identical to sequences in the reference databases; rare tags display a range of distances.
Figure 1 Genetic Distances between Tags and Reference Sequences The genetic distances between each unique V6 tag (A) and V3 tag (B) and its best hit (or hits) in the appropriate reference database is shown on the vertical axis (see Methods for details); the abundance of the tag is shown on a logarithmic scale on the horizontal axis. Horizontal arrows indicate cumulative totals of tags from most to least abundant. Discrete horizontal rows of symbols near the x-axis correspond to an integer number of nucleotide changes relative to a reference sequence; vertical arrows indicate cumulative tag totals for up to 0, 1, or 2 changes. Abundant tags are likely to be identical to sequences in the reference databases; rare tags display a range of distances.CC BY · PubMed Central
Figure 2 Rank Abundance Curves OTU abundance is shown on a logarithmic scale on the vertical axis; OTUs (defined as described in Methods) are listed in rank order along the horizontal axis. The dashed horizontal line at abundance 5 corresponds to an estimated probability of detection of 99%, based on the appearance of a rare OTU in a tag or sequence library according to the Poisson distribution. A comparison of V6, V3, and full-length libraries is shown in (A); the abundance per subject for V6 and V3 refOTUs are shown in (B and C). The maximum V3 refOTU abundance and number of V3 refOTUs are higher for individual A than other participants (C) because three additional samples were analyzed for this subject.
Figure 2 Rank Abundance Curves OTU abundance is shown on a logarithmic scale on the vertical axis; OTUs (defined as described in Methods) are listed in rank order along the horizontal axis. The dashed horizontal line at abundance 5 corresponds to an estimated probability of detection of 99%, based on the appearance of a rare OTU in a tag or sequence library according to the Poisson distribution. A comparison of V6, V3, and full-length libraries is shown in (A); the abundance per subject for V6 and V3 refOTUs are shown in (B and C). The maximum V3 refOTU abundance and number of V3 refOTUs are higher for individual A than other participants (C) because three additional samples were analyzed for this subject.CC BY · PubMed Central
Figure 3 Rarefaction Curves The vertical axis shows the number of OTUs that would be expected to be found after sampling the number of tags or sequences shown on the horizontal axis. Curvature toward the horizontal indicates the increased sequencing effort required to observe novel OTUs when only rare OTUs remain to be discovered. Text boxes indicate the final observed OTU richness (O), range of estimated OTU richness by the ACE, ICE, Chao 1 and Chao 2 nonparametric estimators (E) [61–63], and Good's coverage (C) [64] for each method. The nonparametric estimators indicate that total OTU richness is much higher than currently observed, but are known to underestimate the true richness when the number of observations (i.e., tags or sequences) is small relative to the size of the community [60,63]. Good's coverage, the proportion of tags or sequences found in OTUs containing at least one other member, is an estimate of the probability that a tag or sequence drawn at random from the pool of amplicons will belong to an OTU that has already been detected.
Figure 3 Rarefaction Curves The vertical axis shows the number of OTUs that would be expected to be found after sampling the number of tags or sequences shown on the horizontal axis. Curvature toward the horizontal indicates the increased sequencing effort required to observe novel OTUs when only rare OTUs remain to be discovered. Text boxes indicate the final observed OTU richness (O), range of estimated OTU richness by the ACE, ICE, Chao 1 and Chao 2 nonparametric estimators (E) [61–63], and Good's coverage (C) [64] for each method. The nonparametric estimators indicate that total OTU richness is much higher than currently observed, but are known to underestimate the true richness when the number of observations (i.e., tags or sequences) is small relative to the size of the community [60,63]. Good's coverage, the proportion of tags or sequences found in OTUs containing at least one other member, is an estimate of the probability that a tag or sequence drawn at random from the pool of amplicons will belong to an OTU that has already been detected.CC BY · PubMed Central
Figure 4 Relative Abundance of Taxa across Samples The heatmaps show the relative abundance per sample of V3 refOTUs with total abundance of at least ten, after normalizing to an equal number of tags per sample (see Methods). Color intensity for all panels is directly proportional to the logarithm of normalized OTU abundance from 0 to 300; the 473 highest refOTU abundance values per sample, ranging from 300 to 19,964, are shown at maximum color intensity. Each column in the heatmaps represents one sample, arranged chronologically from left to right within individuals; blue bars above columns indicate Cp-associated samples. Each row represents a V3 refOTU, arranged alphabetically in a taxonomic hierarchy from phylum to genus, and by decreasing abundance within a genus. (A) All 1,450 V3 refOTUs with total normalized abundance of at least ten. The staggered bars on the left indicate phyla (Ac = Actinobacteria, Ba = Bacteroidetes, Fi = Firmicutes, Pr = Proteobacteria, Ve = Verrucomicrobia). Numbers on the right represent prominent genera or higher taxonomic ranks when refOTUs could not be classified to the genus level (see Methods for details): 1. Bifidobacteria, 2. Bacteroides, 3. Parabacteroides, 4. Alistipes, 5. Oscillospira, 6. Dialister, 7. Clostridium, 8. Dorea, 9. Faecalibacterium, 10. Subdoligranulum, 11. Clostridiaceae (family), 12. Eubacterium, 13. Anaerostipes, 14. Coprococcus and Lachnospira (2 thin bands at this position), 15. Roseburia, 16. Ruminococcus, 17. Lachnospiraceae (family), 18. Clostridiales (order), 19. Firmicutes (phylum), 20. Sutterella, 21. Akkermansia. (B–D) The normalized relative abundance in detail (same data as (A)) for V3 refOTUs in the three most abundant genera, Bacteroides, Faecalibacterium, and Roseburia.
Figure 4 Relative Abundance of Taxa across Samples The heatmaps show the relative abundance per sample of V3 refOTUs with total abundance of at least ten, after normalizing to an equal number of tags per sample (see Methods). Color intensity for all panels is directly proportional to the logarithm of normalized OTU abundance from 0 to 300; the 473 highest refOTU abundance values per sample, ranging from 300 to 19,964, are shown at maximum color intensity. Each column in the heatmaps represents one sample, arranged chronologically from left to right within individuals; blue bars above columns indicate Cp-associated samples. Each row represents a V3 refOTU, arranged alphabetically in a taxonomic hierarchy from phylum to genus, and by decreasing abundance within a genus. (A) All 1,450 V3 refOTUs with total normalized abundance of at least ten. The staggered bars on the left indicate phyla (Ac = Actinobacteria, Ba = Bacteroidetes, Fi = Firmicutes, Pr = Proteobacteria, Ve = Verrucomicrobia). Numbers on the right represent prominent genera or higher taxonomic ranks when refOTUs could not be classified to the genus level (see Methods for details): 1. Bifidobacteria, 2. Bacteroides, 3. Parabacteroides, 4. Alistipes, 5. Oscillospira, 6. Dialister, 7. Clostridium, 8. Dorea, 9. Faecalibacterium, 10. Subdoligranulum, 11. Clostridiaceae (family), 12. Eubacterium, 13. Anaerostipes, 14. Coprococcus and Lachnospira (2 thin bands at this position), 15. Roseburia, 16. Ruminococcus, 17. Lachnospiraceae (family), 18. Clostridiales (order), 19. Firmicutes (phylum), 20. Sutterella, 21. Akkermansia. (B–D) The normalized relative abundance in detail (same data as (A)) for V3 refOTUs in the three most abundant genera, Bacteroides, Faecalibacterium, and Roseburia.CC BY · PubMed Central
Figure 5 Diversity Statistics (A) Observed taxon richness (number of V3 refOTUs) per sample; Cp-associated samples have significantly fewer OTUs than pre- and post-Cp samples for individuals A and B (p < 0.005) but not individual C (p = 0.129). (B) Shannon diversity index; Cp-associated samples are significantly less diverse than other samples for all individuals (p < 0.001). (C) Shannon equitability index; OTU abundance in Cp-associated samples is significantly less evenly distributed than OTU abundance in other samples for all individuals (p < 0.001 for A and B, p < 0.05 for C). Formulas for diversity and evenness are given in Methods; significance is assessed as the probability that the Cp-associated value is drawn from the lower tail of a normal distribution with mean and variance as calculated from the other samples.
Figure 5 Diversity Statistics (A) Observed taxon richness (number of V3 refOTUs) per sample; Cp-associated samples have significantly fewer OTUs than pre- and post-Cp samples for individuals A and B (p < 0.005) but not individual C (p = 0.129). (B) Shannon diversity index; Cp-associated samples are significantly less diverse than other samples for all individuals (p < 0.001). (C) Shannon equitability index; OTU abundance in Cp-associated samples is significantly less evenly distributed than OTU abundance in other samples for all individuals (p < 0.001 for A and B, p < 0.05 for C). Formulas for diversity and evenness are given in Methods; significance is assessed as the probability that the Cp-associated value is drawn from the lower tail of a normal distribution with mean and variance as calculated from the other samples.CC BY · PubMed Central
Figure 6 PCA of Relative Taxon Abundance Principal component analysis (PCA) of log2-transformed normalized abundance for 1,450 V3 refOTUs with normalized total abundance of at least ten (same data as in Figure 4A). Cp-associated samples are shown with open symbols, other samples with filled symbols. (A) PCA axis 1 (accounting for 35.3% of intersample variation) separates the samples of individual B from those of individuals A and C; PCA axis 2 (18.2% of intersample variation) separates Cp-associated samples from others. The separation of the Cp-associated samples from others is greatest for individual A, intermediate for B, and least for C, consistent with the heatmaps (Figure 4) and diversity statistics (Figure 5). (B) PCA axis 3 (9.7% of intersample variation) captures temporal variability in non-Cp samples of individual A, and to a lesser extent, individual C. Three samples collected from individual A in the week prior to Cp treatment cluster together at one extreme of the range of axis 3 values. (C) PCA axis 2 versus PCA axis 3. (D) Scree plot showing the proportion of variance explained by the first 5 PCA axes; the dashed line at 0.059 indicates the amount of variance expected for each axis with random, uncorrelated data.
Figure 6 PCA of Relative Taxon Abundance Principal component analysis (PCA) of log2-transformed normalized abundance for 1,450 V3 refOTUs with normalized total abundance of at least ten (same data as in Figure 4A). Cp-associated samples are shown with open symbols, other samples with filled symbols. (A) PCA axis 1 (accounting for 35.3% of intersample variation) separates the samples of individual B from those of individuals A and C; PCA axis 2 (18.2% of intersample variation) separates Cp-associated samples from others. The separation of the Cp-associated samples from others is greatest for individual A, intermediate for B, and least for C, consistent with the heatmaps (Figure 4) and diversity statistics (Figure 5). (B) PCA axis 3 (9.7% of intersample variation) captures temporal variability in non-Cp samples of individual A, and to a lesser extent, individual C. Three samples collected from individual A in the week prior to Cp treatment cluster together at one extreme of the range of axis 3 values. (C) PCA axis 2 versus PCA axis 3. (D) Scree plot showing the proportion of variance explained by the first 5 PCA axes; the dashed line at 0.059 indicates the amount of variance expected for each axis with random, uncorrelated data.CC BY · PubMed Central
Figure 7 Abundant Taxa in the genus Bacteroides The relative abundance per subject of Bacteroides V3 refOTUs, expressed as the percentage of all V3 tags from that subject. The 19 most abundant Bacteroides refOTUs range from the first to the 91st most abundant taxa overall. Eighteen of these 19 Bacteroides refOTUs differ significantly in abundance between subjects (p < 0.05, FDR = 1.9%, NS marks the exception), but the abundance of the Bacteroides genus as a whole does not (p = 0.075, FDR 15%). Numbers in the legend indicate the rank order normalized abundance of refOTUs within Bacteroides, and correspond to the designation of the OTU according to the convention of this report (i.e., “1” represents V3_Bacteroides_refOTU_1.) The dominant tag in 15 of the 19 most abundant Bacteroides refOTUs has a perfect match to reference sequences from the cultivated species named in the legend.
Figure 7 Abundant Taxa in the genus Bacteroides The relative abundance per subject of Bacteroides V3 refOTUs, expressed as the percentage of all V3 tags from that subject. The 19 most abundant Bacteroides refOTUs range from the first to the 91st most abundant taxa overall. Eighteen of these 19 Bacteroides refOTUs differ significantly in abundance between subjects (p < 0.05, FDR = 1.9%, NS marks the exception), but the abundance of the Bacteroides genus as a whole does not (p = 0.075, FDR 15%). Numbers in the legend indicate the rank order normalized abundance of refOTUs within Bacteroides, and correspond to the designation of the OTU according to the convention of this report (i.e., “1” represents V3_Bacteroides_refOTU_1.) The dominant tag in 15 of the 19 most abundant Bacteroides refOTUs has a perfect match to reference sequences from the cultivated species named in the legend.CC BY · PubMed Central
Figure 8 Individualized Cp Responses Normalized abundance is shown on the vertical axis for selected V3 refOTUs (scales differ between panels); samples are ordered chronologically along the horizontal axis. Cp-associated samples are shown with open symbols. (A–H) Eight taxa among the 90 most abundant V3 refOTUs that show contrasting responses to Cp among individuals. Temporal variability is also evident at times not associated with Cp use.
Figure 8 Individualized Cp Responses Normalized abundance is shown on the vertical axis for selected V3 refOTUs (scales differ between panels); samples are ordered chronologically along the horizontal axis. Cp-associated samples are shown with open symbols. (A–H) Eight taxa among the 90 most abundant V3 refOTUs that show contrasting responses to Cp among individuals. Temporal variability is also evident at times not associated with Cp use.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 95 references

Research works printed but not linked: 89

  1. Dethlefsen, 2007, Nature, 449, 811
  2. Ley, 2006, Cell, 124, 837
  3. Guarner, 2006, Digestion, 73, 5
  4. Brook, 2005, Otolaryngol Head Neck Surg, 133, 139
  5. Servin, 2004, FEMS Microbiol Rev, 28, 405
  6. Reid, 2006, World J Urol, 24, 28
  7. Li, 2008, Proc Natl Acad Sci U S A, 105, 2117
  8. Hooper, 2004, Trends Microbiol, 12, 129
  9. Mazmanian, 2005, Cell, 122, 107
  10. Rakoff-Nahoum, 2004, Cell, 118, 229
  11. Sullivan, 2001, Lancet Infect Dis, 1, 101
  12. Beaugerie, 2004, Best Pract Res Clin Gastroenterol, 18, 337
  13. Wilcox, 2003, Best Pract Res Clin Gastroenterol, 17, 475
  14. Marra, 2006, Chest, 129, 610
  15. Noverr, 2005, Clin Exp Allergy, 35, 1511
  16. Prioult, 2005, Immunol Rev, 206, 204
  17. Nicholson, 2005, Nat Rev Microbiol, 3, 431
  18. O'Keefe, 2007, J Nutr, 137, 175S
  19. McGarr, 2005, J Clin Gastroenterol, 39, 98
  20. Ley, 2005, Proc Natl Acad Sci U S A, 102, 11070
  21. Bäckhed, 2004, Proc Natl Acad Sci U S A, 101, 15718
  22. Stewart, 2004, FEMS Microbiol Lett, 230, 1
  23. Lode, 2001, Scand J Infect Dis, 33, 899
  24. De La Cochetiere, 2005, J Clin Microbiol, 43, 5588
  25. Donskey, 2003, J Microbiol Meth, 54, 249
  26. Jernberg, 2007, Isme J, 1, 56
  27. Lofmark, 2008, Anaerobe, 14, 157
  28. Sjolund, 2003, Ann Intern Med, 139, 483
  29. Bäckhed, 2005, Science, 307, 1915
  30. Eckburg, 2005, Science, 308, 1635
  31. Suau, 1999, Appl Environ Microbiol, 65, 4799
  32. Zoetendal, 2004, J Nutr, 134, 465
  33. Mai, 2004, J Nutr, 134, 459
  34. Bartosch, 2004, Appl Environ Microbiol, 70, 3575
  35. Bartosch, 2005, Clin Infect Dis, 40, 28
  36. Vanhoutte, 2004, FEMS Microbiol Ecol, 48, 437
  37. Jernberg, 2005, Appl Environ Microbiol, 71, 501
  38. Margulies, 2005, Nature, 437, 376
  39. Sogin, 2006, Proc Natl Acad Sci U S A, 103, 12115
  40. Liu, 2007, Nucleic Acids Res, 35, e120
  41. Wang, 2007, Appl Environ Microbiol, 73, 5261
  42. Huber, 2007, Science, 318, 97
  43. Huse, 2007, Genome Biol, 8, R143
  44. Roesch, 2007, Isme J, 1, 283
  45. Hamady, 2008, Nat Methods, 5, 235
  46. Sundquist, 2007, BMC Microbiol, 7, 108
  47. Thompson, 2002, Nucleic Acids Res, 30, 2083
  48. Ewing, 1998, Genome Res, 8, 186
  49. Ewing, 1998, Genome Res, 8, 175
  50. Gordon, 1998, Genome Res, 8, 195
  51. DeSantis, 2006, Nucleic Acids Res, 34, W394
  52. DeSantis, 2006, Appl Environ Microbiol, 72, 5069
  53. Ludwig, 2004, Nucleic Acids Res, 32, 1363
  54. Schloss, 2005, Appl Environ Microbiol, 71, 1501
  55. Pruesse, 2007, Nucleic Acids Res, 35, 7188
  56. Colwell, 2005, EstimateS: Statistical estimation of species richness and shared species from samples. Version 7.5
  57. Leek, 2006, Bioinformatics, 22, 507
  58. Hughes, 2001, Appl Environ Microbiol, 67, 4399
  59. Chao, 1984, Scan J Stat, 11, 265
  60. Chao, 1992, Biometrics, 48, 201
  61. Colwell, 1994, Philos Trans R Soc Lond B Biol Sci, 345, 101
  62. Good, 1953, Biometrika, 40, 237
  63. Derrien, 2004, Int J Syst Evol Microbiol, 54, 1469
  64. Jost, 2006, Oikos, 113, 363
  65. Jost, 2007, Ecology, 88, 2427
  66. Franks, 1998, Appl Environ Microbiol, 64, 3336
  67. Matsuki, 2004, Appl Environ Microbiol, 70, 7220
  68. Hayashi, 2002, Microbiol Immunol, 46, 819
  69. De La Cochetiere, 2008, Microb Ecol, 56, 395
  70. Ozaki, 2004, J Med Microbiol, 53, 167
  71. Flint, 2007, Environ Microbiol, 9, 1101
  72. Belenguer, 2006, Appl Environ Microbiol, 72, 3593
  73. Martin, 2007, Mol Syst Biol, 3, 112
  74. Ridlon, 2006, J Lipid Res, 47, 241
  75. Pena, 2004, Appl Environ Microbiol, 70, 558
  76. Servin, 2003, Best Pract Res Clin Gastroenterol, 17, 741
  77. Sullivan, 2003, J Antimicrob Chemother, 52, 308
  78. Bedford Russell, 2006, Bjog, 113, 758
  79. Young, 2004, J Clin Microbiol, 42, 1203
  80. Duncan, 2004, Appl Environ Microbiol, 70, 5810
  81. Duncan, 2006, Int J Syst Evol Microbiol, 56, 2437
  82. Louis, 2004, J Bacteriol, 186, 2099
  83. Schumacher, 1997, Clin Microbiol Infect, 3, 134
  84. Jacoby, 2005, Clin Infect Dis 41 Suppl, 2, S120
  85. Forney, 2004, Curr Opin Microbiol, 7, 210
  86. von Wintzingerode, 1997, FEMS Microbiol Rev, 21, 213
  87. Ley, 2006, Nature, 444, 1022
  88. von Mering, 2007, Science, 315, 1126
  89. Ashelford, 2006, Appl Environ Microbiol, 72, 5734

Cited by

See all 2,361

Metadata

Authors
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A.
Affiliations
  • Stanford University (US)
  • Marine Biological Laboratory (US)
  • VA Palo Alto Health Care System (US)
Corresponding author
Relman, David A
Venue
PLoS Biology
Published
2008-11-18
Volume
6
Issue
11
Pages
e280
ISSN
  • 1544-9173 (ISSN-L)
  • 1545-7885
OpenAlex
W1967821667
Cited by
2,361
References
95
Citations by year
2026: 60 · 2025: 81 · 2024: 89 · 2023: 96 · 2022: 123 · 2021: 142 · 2020: 172 · 2019: 159 · 2018: 155 · 2017: 161 · 2016: 164 · 2015: 174 · 2014: 158 · 2013: 159 · 2012: 138
FWCI
45.07
Type
journal article
Language
en
Open access
Locations
  • PLoS Biology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Open Access Server of the Woods Hole Scientific Community (Woods Hole Scientific Community) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • National Institutes of Health (DP1OD000964)
  • National Institute of Environmental Health Sciences (P50ES012742)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Physical Sciences › Environmental Science › Ecology › Microbial Community Ecology and Physiology
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords
ciprofloxacin, antibiotic effects on gut microbiota, human gut microbiome, 16S rRNA gene pyrosequencing, rare biosphere, bacterial community diversity, interindividual variability, community recovery, functional redundancy, community resilience
MeSH terms
Anti-Bacterial Agents, Bacteria, Base Sequence, Ciprofloxacin, Feces, Humans, Intestines, RNA, Bacterial, RNA, Ribosomal, 16S, Genetic Variation, Principal Component Analysis, Gastrointestinal Tract

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing. https://app.cochat.ai/papers/10.1371/journal.pbio.0060280
The paper
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008). The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing. PLoS Biology. https://doi.org/10.1371/journal.pbio.0060280

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.